d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A phase Ib/II, multicenter, open-label study to evaluate the efficacy of AUY922 in combination with trastuzumab in patients with locally advanced or metasatatic HER2-positive breast cancer, that has progressed after or during at least one Trastuzumab-con [Country] SE [Cancer type] 
Breast cancer
Nordic NECT - Inclusion completed
Cancer type